Zobrazeno 1 - 10
of 44
pro vyhledávání: '"A. Meizler"'
Publikováno v:
Heliyon, Vol 9, Iss 11, Pp e21738- (2023)
Poly-halogenated phenols generated from a range of industrial processes can find their way into rivers and ground water. Here we report on a potential treatment for reducing the toxicity of these aqueous pollutants using two highly toxic penta-haloge
Externí odkaz:
https://doaj.org/article/220b1cc08b604765a3c206fcdbad2335
Publikováno v:
In Heliyon November 2023 9(11)
Autor:
Underwood, Claire *, Collins, Simon N., van Eps, Andrew W., Mills, Paul C., Allavena, Rachel E., Bailey, Simon R., Medina Torres, Carlos E., Meizler, Alon, Pollitt, Christopher C.
Publikováno v:
In The Veterinary Journal September 2015 205(3):357-363
Publikováno v:
In The Veterinary Journal December 2012 194(3):309-313
Publikováno v:
In Chemical Engineering Journal 15 August 2011 172(2-3):792-798
Cotton crop response was evaluated using the growth regulator FIX in a conventional liquid formulation compared to an equivalent rate of a newly developed dry flowable (DF) formulation. The DF formulation will be available in 1996 in water soluble pa
Externí odkaz:
http://hdl.handle.net/10150/210771
Autor:
Andrew W. van Eps, C. Underwood, Christopher C. Pollitt, S.N. Collins, Simon R. Bailey, A. Meizler, Paul C. Mills, Carlos Eduardo Medina Torres, Rachel Allavena
Publikováno v:
The Veterinary Journal. 205:357-363
No validated laminitis drug therapy exists, yet pharmaceutical agents with potential for laminitis prevention have been identified. Many of these are impractical for systemic administration but may be effective if administered locally. This study com
Publikováno v:
The Veterinary Journal. 194:309-313
Tapentadol (TAP) is a novel opioid pain reliever drug with a dual mechanism of action (mu opioid receptor agonist and noradrenaline reuptake inhibitor). It is used as an analgesic in humans, but could be of interest for veterinary species if it has a
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 35:2-77
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. :148-153
Tapentadol (TAP) is a novel opioid pain reliever drug that is unusual in its possession of dual mechanism of action (mu opioid-receptor agonist and noradrenaline reuptake inhibitor), this feature makes the active ingredient an attractive potential pr